In:
International Journal of Cancer, Wiley, Vol. 138, No. 10 ( 2016-05-15), p. 2357-2367
Abstract:
What's new? Soluble forms of tumor necrosis factor receptors, such as sCD27 and sCD30, are markers of B cell activation that can be readily measured in the blood stream. In this case‐control study combined with a meta‐analysis of previous studies, the authors examined the relationship between the two markers and the risk to develop B cell malignancies, in the general population. Their findings support the notion that chronic B‐cell activation is an important mechanism involved in B‐cell lymphomagenesis, which could be clinically exploited for developing risk prediction models in the future.
Type of Medium:
Online Resource
ISSN:
0020-7136
,
1097-0215
Language:
English
Publisher:
Wiley
Publication Date:
2016
detail.hit.zdb_id:
218257-9
detail.hit.zdb_id:
1474822-8